1588. Weight Change among People Living with HIV who switch from Oral Antiviral Therapy to Long Acti...
1588. Weight Change among People Living with HIV who switch from Oral Antiviral Therapy to Long Acting Injectable Cabotegravir/Rilpivirine in a University-Based Clinic
About this item
Full title
Author / Creator
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
More information
Scope and Contents
Contents
Abstract
Background
Integrase strand transfer inhibitors (INSTIs) are a key component of antiretroviral therapy (ART) for HIV treatment, but associated weight gain limits their use in some patients. This study measures weight in people living with HIV (PLWH) who switched to long-acting injectable (LAI) cabotegravir-rilpivirine (CAB) from oral...
Alternative Titles
Full title
1588. Weight Change among People Living with HIV who switch from Oral Antiviral Therapy to Long Acting Injectable Cabotegravir/Rilpivirine in a University-Based Clinic
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1093_ofid_ofad500_1423
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_ofid_ofad500_1423
Other Identifiers
ISSN
2328-8957
E-ISSN
2328-8957
DOI
10.1093/ofid/ofad500.1423
